From: Prognostic value of CT-based radiomics in grade 1–2 pancreatic neuroendocrine tumors
Outcome | Variable | C-model | CR-model | ||
---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | ||
Recurrence-free survival | |||||
Age | 1.005 (0.985–1.025) | 0.626 | 1.004 (0.984–1.024) | 0.703 | |
AJCC stage | < 0.001 | < 0.001 | |||
I | 1 (Ref) | 1 (Ref) | |||
II | 2.989 (1.422–6.286) | 0.004 | 0.881 (0.369–2.107) | 0.777 | |
III | 9.542 (4.166–21.854) | < 0.001 | 2.947 (1.176–7.386) | 0.021 | |
IV | 17.288 (6.602–45.269) | < 0.001 | 4.862 (1.725–13.709) | 0.003 | |
R-score | – | – | 3.681 (2.353–5.759) | < 0.001 | |
Overall survival | |||||
Age | 1.054 (1.021–1.088) | 0.001 | 1.057 (1.023–1.092) | 0.001 | |
AJCC stage | 0.011 | 0.101 | |||
I | 1 (Ref) | 1 (Ref) | |||
II | 1.408 (0.631–3.144) | 0.404 | 0.609 (0.222–1.668) | 0.334 | |
III | 3.224 (1.164–8.930) | 0.024 | 1.264 (0.387–4.124) | 0.698 | |
IV | 7.509 (2.344–24.058) | 0.001 | 2.564 (0.670–9.814) | 0.169 | |
R-score | – | – | 2.296 (1.322–3.989) | 0.003 |